March 22, 2023
Dear all,Company name:

SUNCORPORATIONName of representative: Ryusuke Utsumi,
CEO(Code No. 6736 TSE Standard)Contact:

Yoshimi Kimura,
Senior Managing Director(Tel 052-756-5981)

Notice on the forecast results and dividends for the year ending March 2023
Please ve advised that SUNCORPORATION has decided to revise its previously undisclosed forecast of fullyear results and dividends for the year ending March 31, 2023 as follows.

1. Performance forecast(1) Reasons for earnings forecast
Based on recent economic trends and the financial results of overseas subsidiaries and other entities, theCompany is announcing the following consolidated earnings forecast for the year ending March 31, 2023,
which had not yet been announced.
(2) Forecasted monthly consolidated results for the year ending March 2023 (April 1 2022 – March 31 2023)

PeriodSales

Operatingprofits

Ordinaryprofits（Unit：million JPY）
Net profit for
Net profit for
the yearthe year per
attributable toshare
the parentcompany

Forecasts for this time

36,50037,500-1,650-1,750

14,00015,000

6,5007,500

250.00350.00yen（Reference）
Previouse year’s results（FY ended in March31, 2022）

37,205

1,360

9,674

2,818

117.77yen

Increase/decrease fromthe previouse year (%)-1.89-0.79-44.7-55.1

130.6-166.1

112.3-197.2

In the current financial year, Cellebrite DI Ltd ('Cellebrite'), which was a consolidated subsidiary became anequity method affiliate from the fourth quarter due to a change in the Company's shareholding. As a result of
this change, Cellebrite's income statement for the fourth quarter is presented in the Company's consolidated
income statement as equity in earnings for the fourth quarter.
In addition, in the merger agreement entered into when Cellebrite was listed on the NASDAQ market on
August 30 2021, when it was a consolidated subsidiary of the Company, a price adjustment clause, certain
restricted shares and warrant liabilities assumed from TWC Tech Holdings II Corp. were recognised asliabilities. This liability is subject to changes in fair value due to changes in Cellebrite's share price and otherfactors that affect the Group's results of operations and financial position. For further details, please refer tothe 'Notice on non-operating Income' published on March 15 2022.
The closing date of the equity method affiliates and overseas subsidiaries, including Cellebrite, is December
31 2022. The financial statements of these companies as at that date are used in the forecasting of
consolidated results, but necessary adjustments are made in consolidation to account for material
discrepancies in accounting records relating to transactions between consolidated companies arising fromthe difference between that date and the consolidated closing date.

2. Dividend forecasts
Annual dividend（yen）
End of second quarterEnd of termPreviouse

Total amountUndecided

Undecided

20.00

20.00

20.00

40.00

forecase
Revisedforecast
Actual resultfor this term
Results of the020.00

previouse year
(2) Reasons for the announcement of the dividend forecast
The Company's basic policy is to actively and flexibly distribute profit dividends in line with businessperformance, taking into consideration medium- and long-term free cash flow and the dividend payout ratio,in order to develop business for the future, strengthen the management base and increase corporate value
over the medium term.
For the dividend for the year under review, the Company has decided to set the year-end dividend forecast
at 20 yen per share, taking into account the solid performance of the year under review and the financial
position of the Company.